04.12.2012 Views

Design of functional dendritic polymers for application as drug and ...

Design of functional dendritic polymers for application as drug and ...

Design of functional dendritic polymers for application as drug and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Sideratou et al: Dendritic <strong>polymers</strong> <strong>for</strong> <strong>application</strong> <strong>as</strong> <strong>drug</strong> <strong>and</strong> gene delivery systems<br />

determined in detail, but it is presumably b<strong>as</strong>ed on<br />

acid-b<strong>as</strong>e interactions between the anionic phosphate<br />

moieties on the DNA backbone <strong>and</strong> the primary <strong>and</strong><br />

tertiary amines <strong>of</strong> the dendrimers, which are positively<br />

charged under physiological conditions. It h<strong>as</strong> also been<br />

found (Tang et al, 1996) that partially degraded (or<br />

fragmented) dendrimers, are more appropriate <strong>for</strong> gene<br />

delivery than the intact dendrimers <strong>and</strong> a fragmentation (or<br />

activation step) consisting <strong>of</strong> hydrolytic cleavage <strong>of</strong> the<br />

amide bonds is needed to enhance the transfection. These<br />

dendrimers are characterized <strong>as</strong> activated <strong>and</strong> are shown in<br />

Figure 24. It h<strong>as</strong> been concluded from several<br />

investigations that the spherical shape <strong>of</strong> dendrimers is not<br />

advantageous in gene delivery. This agrees with earlier<br />

work, where ‘fragmented’ PAMAM dendrimers show<br />

NH2 H2N O N<br />

H<br />

N<br />

N<br />

H<br />

O<br />

N<br />

O<br />

O<br />

H<br />

N O<br />

H<br />

N N<br />

N N<br />

N<br />

H<br />

O<br />

H<br />

N<br />

O<br />

O<br />

N<br />

N N<br />

H<br />

H<br />

O N<br />

O<br />

H<br />

N<br />

N O<br />

O<br />

N<br />

H<br />

N<br />

O<br />

N<br />

H<br />

H<br />

H<br />

NH H 2 2N H<br />

N<br />

H N<br />

O<br />

N H H<br />

O N<br />

NH2 H2N H<br />

N O O<br />

O<br />

N<br />

N<br />

O<br />

H<br />

H<br />

H<br />

N<br />

2N<br />

H NH2 NH<br />

N<br />

2<br />

N<br />

O<br />

N<br />

N H<br />

H<br />

O H<br />

N<br />

2N<br />

O<br />

H N<br />

N<br />

O<br />

H H<br />

N<br />

2N<br />

O<br />

N O<br />

H<br />

N<br />

H<br />

H<br />

O N<br />

N<br />

N NH2 H2N N<br />

O<br />

N O<br />

O<br />

NH2 H<br />

N O<br />

H<br />

H<br />

O<br />

N<br />

H<br />

N N<br />

H<br />

N N<br />

O<br />

O<br />

H N<br />

N H<br />

2N<br />

O<br />

H<br />

N<br />

H N<br />

NH<br />

2N O<br />

O<br />

2<br />

N<br />

H<br />

H N<br />

O N<br />

O<br />

H<br />

N<br />

H<br />

N<br />

N<br />

O<br />

H H<br />

2N<br />

N O<br />

N<br />

H O<br />

2N<br />

O O<br />

N<br />

H<br />

N<br />

N N<br />

H H<br />

H<br />

O N<br />

N<br />

N<br />

O<br />

O<br />

O<br />

N<br />

H O<br />

H<br />

O N<br />

2N H2N N N<br />

H N<br />

N H<br />

H<br />

H<br />

H<br />

N O<br />

O N<br />

N<br />

O<br />

N<br />

NH O O<br />

2 H H<br />

N<br />

2N H N N H NH2 H<br />

O NH2 N<br />

N H<br />

H<br />

O<br />

N<br />

O NH2 N N NH2 H<br />

H<br />

O N<br />

O<br />

N<br />

NH2 N NH2 H<br />

O<br />

N H<br />

H2N NH2 H2N Figure 24. Structural features <strong>of</strong> intact vs activated PAMAM Dendrimers.<br />

superior transfection efficacy in comparison with the<br />

spherical ‘intact’ dendrimers (Bo<strong>as</strong> <strong>and</strong> Heegaard, 2004).<br />

In comparison to the intact dendrimers, the partially<br />

degraded dendrimers have a more flexible structure (fewer<br />

amide bonds) <strong>and</strong> <strong>for</strong>m a more compact complex with<br />

DNA, which is preferable <strong>for</strong> gene delivery by the<br />

endocytotic pathway (Dennig <strong>and</strong> Duncan, 2002). In<br />

addition, it is generally found that the maximum<br />

transfection efficiency (Figure 25) is obtained with an<br />

excess <strong>of</strong> primary amines to DNA phosphates, yielding a<br />

positive net charge <strong>of</strong> the complexes The more flexible<br />

higher generation DAB dendrimers (containing no amides)<br />

are found to be too cytotoxic <strong>for</strong> use <strong>as</strong> non-viral gene<br />

vectors, however, the lower generation dendrimers are<br />

well-suited <strong>for</strong> gene delivery (Zinselmeyer et al, 2002).<br />

H 2N<br />

H 2N<br />

H 2N<br />

O<br />

N<br />

H<br />

HO<br />

H 2N<br />

HO<br />

N<br />

O<br />

N O<br />

H N<br />

O<br />

O<br />

N<br />

H<br />

N<br />

H<br />

N<br />

O<br />

H<br />

HO<br />

N O<br />

O<br />

HO<br />

H<br />

O<br />

N<br />

O<br />

O<br />

N<br />

H<br />

O<br />

N<br />

HO<br />

N<br />

O<br />

N<br />

N<br />

H<br />

HO<br />

N O<br />

O<br />

N<br />

H<br />

N<br />

H<br />

N<br />

O<br />

O<br />

HO<br />

O<br />

O<br />

N<br />

H H<br />

N N<br />

H N<br />

O<br />

H<br />

N<br />

N<br />

O<br />

O<br />

N<br />

N<br />

H<br />

O<br />

N H<br />

O<br />

N<br />

N<br />

H<br />

N<br />

O<br />

H N<br />

N<br />

O<br />

H N<br />

NH 2<br />

H 2N<br />

N H<br />

O<br />

N H<br />

O H<br />

N<br />

O<br />

O<br />

OH<br />

N<br />

N<br />

OH<br />

O<br />

O<br />

O<br />

N<br />

OH<br />

O<br />

N<br />

O<br />

N<br />

H<br />

N<br />

H<br />

N<br />

O<br />

Figure 25. Transfection efficacy <strong>of</strong> poly(propylene imine) dendrimers <strong>of</strong> various generations (G1-G5) relative to N-[1-(2,3dioleoyloxy)propyl]-N,N,N-trimethylammonium<br />

methylsulphate (DOTAP) in the A431 cell line studied in 96-well plates. DAB G1 <strong>and</strong><br />

DAB G2 were dosed at a dendrimer: DNA ratio <strong>of</strong> 5:1, <strong>and</strong> a DNA dose <strong>of</strong> 20 µg per well w<strong>as</strong> used. DAB G3 w<strong>as</strong> also dosed at a<br />

dendrimer: DNA ratio <strong>of</strong> 5:1, but a DNA dose <strong>of</strong> 5 µg per well DNA w<strong>as</strong> used; DAB G4 <strong>and</strong> DAB G5 were dosed at a dendrimer: DNA<br />

ratio <strong>of</strong> 3:1 <strong>and</strong> a DNA dose <strong>of</strong> 20 µg per well. DOTAP w<strong>as</strong> dosed at a DOTAP:DNA ratio <strong>of</strong> 5:1, <strong>and</strong> a DNA dose <strong>of</strong> 20 µg per well.<br />

Data represented <strong>as</strong> the mean ±SD <strong>of</strong> at le<strong>as</strong>t 3 replicates. Reproduced from Zinselmeyer et al., 2002 with kind permission from<br />

Springer.<br />

88<br />

N<br />

H<br />

N<br />

O<br />

OH<br />

H<br />

N<br />

O<br />

O<br />

OH<br />

H<br />

O N<br />

NH 2<br />

N<br />

O<br />

N<br />

N<br />

H<br />

H<br />

O N<br />

O N<br />

H<br />

NH 2<br />

O<br />

NH 2<br />

NH 2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!